Project Grant K23DK144694
Award Date 9/1/26
Completion Date 7/31/31
Dollars Obligated $195K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded Rhode Island Hospital $195,475 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to advance understanding of the physiological mechanisms by which infections contribute to stunting and wasting in young children and to support career development of the principal investigator. The research leverages well-characterized samples and clinical data from a completed NIH-funded randomized,...
- The National Institute of Child Health and Human Development awarded Rhode Island Hospital $168,056 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to characterize variations in human milk microRNA profiles and examine relationships between microRNA composition and infant weight gain and immune system maturation. The research leverages an existing longitudinal study of 400 pregnant women and their infants in the Philippines,...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Virginia Commonwealth University $1.863 million on September 12, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a feasibility and pilot study integrating a prescription produce program within a diabetes prevention program for type 2 diabetes prevention. The recipient will conduct a mixed-methods feasibility and pilot study using a randomized controlled trial...
- The National Heart, Lung, and Blood Institute awarded Rhode Island Hospital $712,858 on August 20, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of DELTEX E3 ubiquitin ligase 3L (DTX3L) in sepsis-induced insulin resistance and cardiac dysfunction. The research examines whether muscle-specific DTX3L mediates ubiquitination and degradation of HDAC4 as a mechanism to mitigate septic cardiac depression and insulin resistance. The project uses...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Boston Children's Hospital $831,433 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supporting research to redefine the biogeography and function of food proteins in human health and disease. The project establishes first principles of the food-host interactome by developing systematic approaches to map the transit, transformation, and tissue...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Miriam Hospital $111,750 on May 5, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to refine and test an evidence-based healthcare provider training program specific to eating disorder assessment and management in adolescents and young adults with Type 1 Diabetes. Approximately one-third of adolescents and young adults with Type 1 Diabetes develop eating...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded Rhode Island Hospital $343,940 on August 31, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a pilot pre/post interventional clinical trial assessing the efficacy and safety of verapamil in adolescents and adults with cystic fibrosis-related dysglycemia. The trial will...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Harvard Pilgrim Health Care, Inc. $827,060 on August 21, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate California's Medicaid medically tailored grocery program for adults with type 2 diabetes. The project will conduct a rigorous randomized encouragement design study enrolling 600 adults with type 2 diabetes who are Medicaid participants and regular...
- Federal Grant Award Summary Rhode Island Hospital received a $464,615 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 5, 2025, with completion targeted for August 31, 2027. The project, titled "The Context of Food Allergy Management for Latino Children: Identifying Drivers of Health Disparities," addresses documented health disparities in pediatric food...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pennsylvania $808,720 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a longitudinal randomized controlled trial examining how unhealthy food restrictions and healthy food incentives on a monthly food benefit program affect diet quality and program experiences among low-income Americans. The study will enroll 357...